Abstract

Patient-specific quality assurance (QA) is an essential part of intensity-modulated radiotherapy (IMRT) and volumetric arc therapy (VMAT) treatments. This study aims to develop a Patient-specific QA system through the development of a fluence generating programme and utilization of amorphous silicon (aSi) electronic portal imaging device (EPID). The EPID was investigated on the dependency of dose rate, uniformity of detector sensitivity and output factor. A fluence generating programme was written using MATLAB. Five simple dynamic arc plans and one patient VMAT plan were created using the Monaco treatment planning system which were used in the programme to generate fluence maps. The accuracy of the programme was evaluated by performing gamma analysis between the generated and measured fluence. EPID signal was found to be linearly proportional to dose (1-1000 MU) and independent of dose rate. The mean uniformity ratio was 1.07 ± 0.04%. The measured fluence maps were corrected for uniformity before gamma analysis. Output factor and dose deposition were taken into account in the process. The average result of the gamma analysis passed the 95% threshold. A fluence generating programme was developed, serving as the foundation of the Patient-specific QA system using aSi EPID for IMRT/VMAT delivery in this centre.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.